Skip to main navigation Skip to search Skip to main content

A randomised phase 2a study to investigate the effects of blocking interleukin-33 with tozorakimab in patients hospitalised with COVID-19: Accord-2

  • Tom Wilkinson (Lead / Corresponding author)
  • , Anthony De Soyza
  • , Miles Carroll
  • , James D. Chalmers
  • , Michael G. Crooks
  • , Gareth Griffiths
  • , Manu Shankar-Hari
  • , Ling-Pei Ho
  • , Alex Horsley
  • , Chris Kell
  • , Beatriz Lara
  • , Biswa Mishra
  • , Rachel Moate
  • , Clive Page
  • , Hitesh Pandya
  • , Jason Raw
  • , Fred Reid
  • , Dinesh Saralaya
  • , Ian C. Scott
  • , Salman Siddiqui
    • Andy Ustianowski, Natalie van Zuydam, Ashley Woodcock, Dave Singh

    Research output: Contribution to journal › Article › peer-review

    9   Link opens in a new tab Citations (Scopus)
    175 Downloads (Pure)

    Fingerprint

    Dive into the research topics of 'A randomised phase 2a study to investigate the effects of blocking interleukin-33 with tozorakimab in patients hospitalised with COVID-19: Accord-2'. Together they form a unique fingerprint.
    Sort by

    Keyphrases

    Nursing and Health Professions